Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Rijcken CJF"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mihyar R; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany., Shalmani AA; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany., Wildt V; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany., Sheybanifard M; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany., Wang A; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany., May JN; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany., Shahzad S; Ernst Ruska-Centre for Microscopy and Spectroscopy with Electrons (ER - C -3): Structural Biology, Forschungszentrum Jülich, Wilhelm-Johnen-Straße, 52428 Jülich, Germany., Buhl EM; Electron Microscopy Facility, Institute of Pathology, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074 Aachen, Germany., Rütten S; Electron Microscopy Facility, Institute of Pathology, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074 Aachen, Germany., Behrens D; Experimental Pharmacology and Oncology GmbH, Robert-Roessle-Str. 10, 13125 Berlin, Germany., Walther W; Experimental Pharmacology and Oncology GmbH, Robert-Roessle-Str. 10, 13125 Berlin, Germany., Tiboni M; University of Urbino Carlo Bo, Department of Biomolecular Sciences, Via Ca' le Suore 2/4, 61029, Urbino (PU), Italy., Casettari L; University of Urbino Carlo Bo, Department of Biomolecular Sciences, Via Ca' le Suore 2/4, 61029, Urbino (PU), Italy., Buyel JF; Institute of Bioprocess Science and Engineering (IBSE), University of Natural Resources and Life Sciences (BOKU), Department of Biotechnology, Muthgasse 18, 1190 Vienna, Austria., Rijcken CJF; Cristal Therapeutics, Oxfordlaan 55, 6229 EV Maastricht, the Netherlands., Hennink WE; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, 3508 TB Utrecht, the Netherlands., von Stillfried S; Institute of Pathology, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074 Aachen, Germany., Kiessling F; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany., Shi Y; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany., Metselaar JM; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany., Lammers T; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany. Electronic address: tlammers@ukaachen.de., Peña Q; Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Forckenbeckstrasse 55, 52074 Aachen, Germany. Electronic address: jpena@ukaachen.de.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2024 Nov; Vol. 375, pp. 614-626. Date of Electronic Publication: 2024 Sep 23.
Autor:
Joyce P; Centre for Pharmaceutical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia. paul.joyce@unisa.edu.au., Allen CJ; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada., Alonso MJ; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), IDIS Research Institute, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.; Department of Pharmacology, Pharmacy and Pharmaceutical Technology, School of Pharmacy, Universidade de Santiago de Compostela, Santiago de Compostela, Spain., Ashford M; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield, UK., Bradbury MS; Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medical College, New York, NY, USA., Germain M; Curadigm, Nanobiotix, Paris, France., Kavallaris M; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, Faculty of Medicine and Health UNSW, Sydney, New South Wales, Australia.; UNSW Australian Centre for Nanomedicine, Faculty of Engineering, University of New South Wales (UNSW), Sydney, New South Wales, Australia., Langer R; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Lammers T; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Hospital, Aachen, Germany.; Mildred Scheel School of Oncology (MSSO), Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIOABCD), RWTH Aachen University Hospital, Aachen, Germany., Peracchia MT; mRNA Center of Excellence, Sanofi R&D, Marcy l'Etoile, France., Popat A; School of Pharmacy, The University of Queensland, Woolloongabba, Queensland, Australia., Prestidge CA; Centre for Pharmaceutical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Rijcken CJF; Cristal Therapeutics, Maastricht, The Netherlands., Sarmento B; IiS - Institute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.; INEB - Institute for Biomedical Engineering, University of Porto, Porto, Portugal., Schmid RB; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Schroeder A; The Louis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa, Israel., Subramaniam S; Centre for Pharmaceutical Innovation, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia., Thorn CR; BioTherapeutics Pharmaceutical Sciences, Pfizer, Andover, MA, USA., Whitehead KA; Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA., Zhao CX; School of Chemical Engineering, Faculty of Sciences, Engineering and Technology, University of Adelaide, Adelaide, South Australia, Australia.; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, Australia., Santos HA; Department of Biomaterials and Biomedical Technology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. h.a.santos@umcg.nl.; The Personalized Medicine Research Institute (PRECISION), University Medical Center Groningen, Groningen, The Netherlands. h.a.santos@umcg.nl.; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland. h.a.santos@umcg.nl.
Publikováno v:
Nature nanotechnology [Nat Nanotechnol] 2024 Nov; Vol. 19 (11), pp. 1597-1611. Date of Electronic Publication: 2024 Sep 06.
Autor:
Hebels ER; Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3508 TB, The Netherlands., Dietl S; Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3508 TB, The Netherlands., Timmers M; Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3508 TB, The Netherlands.; Cristal Therapeutics, Maastricht 6229 EV, The Netherlands., Hak J; Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3508 TB, The Netherlands., van den Dikkenberg A; Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3508 TB, The Netherlands., Rijcken CJF; Cristal Therapeutics, Maastricht 6229 EV, The Netherlands., Hennink WE; Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3508 TB, The Netherlands., Liskamp RMJ; Cristal Therapeutics, Maastricht 6229 EV, The Netherlands.; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht 6229 ER, The Netherlands.; School of Chemistry, University of Glasgow, Glasgow G12 8QQ, U.K., Vermonden T; Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3508 TB, The Netherlands.
Publikováno v:
Bioconjugate chemistry [Bioconjug Chem] 2023 Dec 20; Vol. 34 (12), pp. 2375-2386. Date of Electronic Publication: 2023 Dec 11.
Autor:
Timmers M; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584 CG, The Netherlands.; Cristal Therapeutics, Maastricht 6229 EV, The Netherlands., Peeters W; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht 6229 ER, The Netherlands., Hauwert NJ; Symeres, Kerkenbos 1013, Nijmegen 6546 BB, The Netherlands., Rijcken CJF; Cristal Therapeutics, Maastricht 6229 EV, The Netherlands., Vermonden T; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht 3584 CG, The Netherlands., Dijkgraaf I; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht 6229 ER, The Netherlands., Liskamp RMJ; Cristal Therapeutics, Maastricht 6229 EV, The Netherlands.; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht 6229 ER, The Netherlands.; School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK. robert.liskamp@glasgow.ac.uk.
Publikováno v:
Chemical communications (Cambridge, England) [Chem Commun (Camb)] 2023 Sep 21; Vol. 59 (76), pp. 11397-11400. Date of Electronic Publication: 2023 Sep 21.
Autor:
Hebels ER; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3508 TB Utrecht, The Netherlands., van Steenbergen MJ; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3508 TB Utrecht, The Netherlands., Haegebaert R; Laboratory for General Biochemistry and Physical Pharmacy, Ghent University, Ottergemsesteenweg 460, 9000 Gent, Belgium., Seinen CW; Division Laboratories, Pharmacy and Biomedical Genetics, Central Diagnostic Lab, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands., Mesquita BS; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3508 TB Utrecht, The Netherlands., van den Dikkenberg A; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3508 TB Utrecht, The Netherlands., Remaut K; Laboratory for General Biochemistry and Physical Pharmacy, Ghent University, Ottergemsesteenweg 460, 9000 Gent, Belgium., Rijcken CJF; Cristal Therapeutics, 6229 EV Maastricht, The Netherlands., van Ravensteijn BGP; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3508 TB Utrecht, The Netherlands., Hennink WE; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3508 TB Utrecht, The Netherlands., Vermonden T; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3508 TB Utrecht, The Netherlands.
Publikováno v:
Langmuir : the ACS journal of surfaces and colloids [Langmuir] 2023 Aug 29; Vol. 39 (34), pp. 12132-12143. Date of Electronic Publication: 2023 Aug 15.
Autor:
Timmers M; Cristal Therapeutics, 6229 EV Maastricht, The Netherlands.; Department of Pharmaceutics, Utrecht Institute for Pharmaceutic Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands., Kipper A; TBD Pharmatech, 50410 Tartu, Estonia., Frey R; Lonza AG, Bioconjugates Development, Rottenstr., 3930 Visp, Switzerland., Notermans S; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 6229 ER Maastricht, The Netherlands., Voievudskyi M; TBD Pharmatech, 50410 Tartu, Estonia., Wilson C; School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK., Hentzen N; Lonza AG, Bioconjugates Development, Rottenstr., 3930 Visp, Switzerland., Ringle M; Lonza AG, Bioconjugates Development, Rottenstr., 3930 Visp, Switzerland., Bovino C; Lonza AG, Bioconjugates Development, Rottenstr., 3930 Visp, Switzerland., Stump B; Lonza AG, Bioconjugates Development, Rottenstr., 3930 Visp, Switzerland., Rijcken CJF; Cristal Therapeutics, 6229 EV Maastricht, The Netherlands., Vermonden T; Department of Pharmaceutics, Utrecht Institute for Pharmaceutic Sciences, Utrecht University, 3584 CG Utrecht, The Netherlands., Dijkgraaf I; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 6229 ER Maastricht, The Netherlands., Liskamp R; Cristal Therapeutics, 6229 EV Maastricht, The Netherlands.; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, 6229 ER Maastricht, The Netherlands.; School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Aug 15; Vol. 16 (8). Date of Electronic Publication: 2023 Aug 15.
Autor:
Boere I; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands i.boere@erasmusmc.nl., Vergote I; Division of Gynaecological Oncology, Leuven Cancer Institute, Department of Gynaecology and Obstetrics, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium., Hanssen R; Cristal Therapeutics, Maastricht, The Netherlands., Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Gennigens C; Department of Medical Oncology, CHU de Liège, Liège, Belgium., Ottevanger P; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., van de Wouw YJ; Department of Internal Medicine, VieCuri Medical Centre, Venlo, The Netherlands., Rijcken CJF; Cristal Therapeutics, Maastricht, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Ledermann J; Department of Oncology, University College London (UCL) Cancer Institute, UCL & UCL Hospitals Comprehensive Biomedical Research Centre, London, UK.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Aug 07; Vol. 33 (8), pp. 1247-1252. Date of Electronic Publication: 2023 Aug 07.